NO20011403D0 - Therapy to improve congestion - Google Patents
Therapy to improve congestionInfo
- Publication number
- NO20011403D0 NO20011403D0 NO20011403A NO20011403A NO20011403D0 NO 20011403 D0 NO20011403 D0 NO 20011403D0 NO 20011403 A NO20011403 A NO 20011403A NO 20011403 A NO20011403 A NO 20011403A NO 20011403 D0 NO20011403 D0 NO 20011403D0
- Authority
- NO
- Norway
- Prior art keywords
- therapy
- improve congestion
- congestion
- improve
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98203454 | 1998-10-16 | ||
PCT/EP1999/007804 WO2000023057A2 (en) | 1998-10-16 | 1999-10-12 | Atypical antiphsychotic in combination with acetylcholinesterase inhibitor for improving cognition |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20011403L NO20011403L (en) | 2001-03-20 |
NO20011403D0 true NO20011403D0 (en) | 2001-03-20 |
Family
ID=8234219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20011403A NO20011403D0 (en) | 1998-10-16 | 2001-03-20 | Therapy to improve congestion |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1121131A2 (en) |
JP (1) | JP2002527469A (en) |
KR (1) | KR20010072878A (en) |
CN (1) | CN1367697A (en) |
AU (1) | AU6472799A (en) |
BG (1) | BG105302A (en) |
BR (1) | BR9914419A (en) |
CA (1) | CA2345767A1 (en) |
EE (1) | EE200100136A (en) |
HK (1) | HK1039745A1 (en) |
HR (1) | HRP20010262A2 (en) |
HU (1) | HUP0103781A3 (en) |
ID (1) | ID28441A (en) |
IL (1) | IL142588A0 (en) |
NO (1) | NO20011403D0 (en) |
PL (1) | PL348107A1 (en) |
SK (1) | SK4592001A3 (en) |
TR (1) | TR200101082T2 (en) |
WO (1) | WO2000023057A2 (en) |
ZA (1) | ZA200103081B (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006201188B2 (en) * | 2001-02-05 | 2007-11-15 | Novartis Ag | New use of iloperidone |
GB0102841D0 (en) * | 2001-02-05 | 2001-03-21 | Novartis Ag | Organic compounds |
CN101912367A (en) * | 2001-10-30 | 2010-12-15 | 诺瓦提斯公司 | The depot formulation of iloperidone and star-shape polymer |
GB0216416D0 (en) | 2002-07-15 | 2002-08-21 | Novartis Ag | Organic compounds |
US20040192754A1 (en) * | 2003-03-24 | 2004-09-30 | Shapira Nathan Andrew | Methods for treating idiopathic hyperhidrosis and associated conditions |
TW200501962A (en) * | 2003-04-01 | 2005-01-16 | Novartis Ag | Use of carbamazepine derivatives for the treatment of agitation in dementia patients |
CA2552221A1 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Donepezil formulations |
CN1922176A (en) * | 2004-12-10 | 2007-02-28 | 艾博特公司 | Condensed bicycle heterocycle substituted quinuclidine derivant |
WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
SI2091948T1 (en) | 2006-11-30 | 2012-07-31 | Probiodrug Ag | Novel inhibitors of glutaminyl cyclase |
ZA200905537B (en) | 2007-03-01 | 2010-10-27 | Probiodrug Ag | New use of glutaminyl cyclase inhibitors |
EP2142514B1 (en) | 2007-04-18 | 2014-12-24 | Probiodrug AG | Thiourea derivatives as glutaminyl cyclase inhibitors |
MX2007008642A (en) * | 2007-07-16 | 2009-02-25 | World Trade Imp Export Wtie Ag | Pharmaceutical composition comprising the combination of a benzisoxazolic derived agent and a reversible inhibiting agent of the cholinesterase enzyme prescribed for the control and treatment of psychotic disorders and dementias. |
US20110212928A1 (en) | 2010-02-09 | 2011-09-01 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
JP6026284B2 (en) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | Inhibitors of glutaminyl cyclase |
JP5688745B2 (en) | 2010-03-10 | 2015-03-25 | プロビオドルグ エージー | Heterocyclic inhibitor of glutaminyl cyclase (QC, EC 2.3.2.5) |
WO2011131748A2 (en) | 2010-04-21 | 2011-10-27 | Probiodrug Ag | Novel inhibitors |
WO2012123563A1 (en) | 2011-03-16 | 2012-09-20 | Probiodrug Ag | Benz imidazole derivatives as inhibitors of glutaminyl cyclase |
EP2919788A4 (en) | 2012-11-14 | 2016-05-25 | Univ Johns Hopkins | Methods and compositions for treating schizophrenia |
US10806717B2 (en) | 2013-03-15 | 2020-10-20 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
ES2881081T3 (en) | 2013-03-15 | 2021-11-26 | Agenebio Inc | Procedures and compositions to improve cognitive function |
JP6899043B2 (en) | 2015-05-22 | 2021-07-07 | エージンバイオ, インコーポレイテッド | Sustained release pharmaceutical composition of levetiracetam |
EP3461819B1 (en) | 2017-09-29 | 2020-05-27 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
WO1992020327A1 (en) * | 1991-05-14 | 1992-11-26 | Ernir Snorrason | Treatment of fatigue syndrome with cholinesterase inhibitors |
WO1999007378A1 (en) * | 1997-08-11 | 1999-02-18 | THE UNIVERSITY OF SOUTH FLORIDA A Corporation of the State of Florida | Nicotine antagonists for nicotine-responsive neuropsychiatric disorders |
RU2219924C2 (en) * | 1998-04-14 | 2003-12-27 | Дзе Дженерал Хоспитал Корпорейшн | Method for treatment of neuropsychiatric disorders |
-
1999
- 1999-10-12 HU HU0103781A patent/HUP0103781A3/en unknown
- 1999-10-12 BR BR9914419-0A patent/BR9914419A/en not_active IP Right Cessation
- 1999-10-12 KR KR1020017002286A patent/KR20010072878A/en not_active Application Discontinuation
- 1999-10-12 JP JP2000576832A patent/JP2002527469A/en not_active Withdrawn
- 1999-10-12 PL PL99348107A patent/PL348107A1/en unknown
- 1999-10-12 CN CN99812184A patent/CN1367697A/en active Pending
- 1999-10-12 WO PCT/EP1999/007804 patent/WO2000023057A2/en not_active Application Discontinuation
- 1999-10-12 CA CA002345767A patent/CA2345767A1/en not_active Abandoned
- 1999-10-12 TR TR2001/01082T patent/TR200101082T2/en unknown
- 1999-10-12 IL IL14258899A patent/IL142588A0/en unknown
- 1999-10-12 AU AU64727/99A patent/AU6472799A/en not_active Abandoned
- 1999-10-12 SK SK459-2001A patent/SK4592001A3/en unknown
- 1999-10-12 ID IDW20010828A patent/ID28441A/en unknown
- 1999-10-12 EP EP99952580A patent/EP1121131A2/en not_active Withdrawn
- 1999-10-12 EE EEP200100136A patent/EE200100136A/en unknown
-
2001
- 2001-03-01 BG BG105302A patent/BG105302A/en unknown
- 2001-03-20 NO NO20011403A patent/NO20011403D0/en not_active Application Discontinuation
- 2001-04-10 HR HR20010262A patent/HRP20010262A2/en not_active Application Discontinuation
- 2001-04-12 ZA ZA200103081A patent/ZA200103081B/en unknown
-
2002
- 2002-01-10 HK HK02100158.6A patent/HK1039745A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
BG105302A (en) | 2001-11-30 |
HRP20010262A2 (en) | 2002-06-30 |
NO20011403L (en) | 2001-03-20 |
BR9914419A (en) | 2001-06-26 |
WO2000023057A3 (en) | 2000-07-27 |
JP2002527469A (en) | 2002-08-27 |
EE200100136A (en) | 2002-06-17 |
AU6472799A (en) | 2000-05-08 |
HUP0103781A3 (en) | 2003-09-29 |
HUP0103781A2 (en) | 2002-03-28 |
CN1367697A (en) | 2002-09-04 |
HK1039745A1 (en) | 2002-05-10 |
WO2000023057A2 (en) | 2000-04-27 |
ZA200103081B (en) | 2002-07-12 |
IL142588A0 (en) | 2002-03-10 |
PL348107A1 (en) | 2002-05-06 |
ID28441A (en) | 2001-05-24 |
SK4592001A3 (en) | 2001-12-03 |
TR200101082T2 (en) | 2001-09-21 |
CA2345767A1 (en) | 2000-04-27 |
KR20010072878A (en) | 2001-07-31 |
EP1121131A2 (en) | 2001-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20011403D0 (en) | Therapy to improve congestion | |
IS6340A (en) | Water gel-powered dosage form | |
ID27841A (en) | THERAPEUTIC BIARILS | |
NO20003640D0 (en) | New dosage form | |
ID26974A (en) | ARILPHENYL-SUBSTITUTED CYCLEIC CETOENOL | |
DE59910140D1 (en) | SLIPFORM | |
DK1637127T3 (en) | THERAPEUTIC MICROSUM | |
DE69941252D1 (en) | RIBBED ELECTRODES | |
DE69924365D1 (en) | MASSAGER | |
ATE321483T1 (en) | CAN | |
FR2806140B1 (en) | DIVIDING WHEEL | |
NO992692D0 (en) | Nefadozone dosage form | |
DE69936958D1 (en) | traffic shaper | |
ID28648A (en) | INTER-LABIAL ABSORPTION DEVICES | |
IS6575A (en) | Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives to treat pain | |
DE69921571D1 (en) | MASSAGER | |
EE200200568A (en) | Therapeutic diphenylether compounds | |
IS6574A (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives to treat pain | |
IS6563A (en) | Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives to treat pain | |
DE60037935D1 (en) | CONTINUOUS TREATMENT SYSTEM | |
NO20005042D0 (en) | Methods to Inhibit MRP1 | |
IT1310385B1 (en) | DEVICE TO IMPROVE BREATHING. | |
NO994872D0 (en) | travel Safe | |
NO20023164D0 (en) | arch structure | |
IT1299030B1 (en) | DEVICE TO PRODUCE SHOES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |